RPL7P49

Across TCGA pan-cancer cohorts, RPL7P49 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RPL7P49 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RPL7P49 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7P49 expression acts as an unfavorable survival marker, although some lineages such as LUAD and BRCA show a favorable association.

UCEC, TGCT, and LUAD are the cancer types where RPL7P49 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	II,III,IV	0.613	0.784	.002	84	view →
TGCT	DFS	Tertile	All	0.664	0.868	.005	54	view →
LUAD	OS	Median	II,III,IV	0.637	0.485	.004	35	view →
THCA	OS	Tertile	IV	0.530	0.914	.014	22	view →
BRCA	OS	Median	III,IV	0.712	0.459	.016	18	view →
UVM	DFS	Tertile	III,IV	0.129	0.673	.017	12	view →
KIRP	OS	Quartile	III,IV	0.213	0.600	.022	8	view →
SKCM	DFS	Quartile	IV	0.016	0.451	.025	6	view →
ESCA	DFS	Tertile	IV	0.221	0.704	.024	6	view →
OV	OS	Quartile	III,IV	0.294	0.414	.025	6	view →
ACC	OS	Tertile	III,IV	1.000	0.495	.041	6	view →
BLCA	DFS	Tertile	III,IV	0.481	0.608	.040	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RPL7P49–UCEC (DFS)

Open the UCEC breakdown →